Yu, H. A., Sima, C., Feldman, D., Liu, L. L., Vaitheesvaran, B., Cross, J., . . . Riely, G. J. (2017). Phase 1 study of twice weekly pulse dose and daily low-dose erlotinib as initial treatment for patients with EGFR-mutant lung cancers(†). Ann Oncol.
Citação norma ChicagoYu, H. A., et al. "Phase 1 Study of Twice Weekly Pulse Dose and Daily Low-dose Erlotinib As Initial Treatment for Patients With EGFR-mutant Lung Cancers(†)." Ann Oncol 2017.
MLA CitationYu, H. A., et al. "Phase 1 Study of Twice Weekly Pulse Dose and Daily Low-dose Erlotinib As Initial Treatment for Patients With EGFR-mutant Lung Cancers(†)." Ann Oncol 2017.
Advarsel: Disse citationer er muligvist ikke 100% nøjagtige.